Table 2.
Functional platelet test | Number of ASD samples | Agonists | Study outcome | References |
---|---|---|---|---|
Aggregation | 14 | ADP, collagen | Reduced platelet aggregation with both agonists but did not reach significance due to low sample size | Safai‐Kutti et al73 |
Aggregation | 7 | ADP and 5‐HT | Reduced 5‐HT amplified aggregation indicating a defect in platelet 5‐HT2 receptor complex | McBridge et al102 |
Aggregation | 17 | ADP | Marginally significant reduction in aggregation in ASD patients with normal platelet 5‐HT levels indicating that the platelet functional defect could be independent of the serotonergic system | Hranilović et al74 |
ATP secretion | 159 | ADP, collagen | Reduced stimulated release of ATP from platelets of ASD patients and first‐degree relatives indicating potentially heritable dense granule secretion defect | Bijl et al59 |
Abbreviations: 5‐HT, 5‐hydroxytryptamine; ASD, autism spectrum disorder.